Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 24, 2023

SELL
$5.67 - $11.2 $22,680 - $44,800
-4,000 Reduced 66.67%
2,000 $0
Q3 2022

Oct 13, 2022

BUY
$3.93 - $8.57 $13,362 - $29,138
3,400 Added 130.77%
6,000 $35,000
Q2 2022

Jul 28, 2022

BUY
$4.02 - $10.43 $7,879 - $20,442
1,960 Added 306.25%
2,600 $12,000
Q4 2021

Jan 24, 2022

BUY
$19.26 - $30.08 $12,326 - $19,251
640 New
640 $13,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.